TLRY Tilray Inc

USD 0.49 +0.05 ( +11.81%)
Icon

Tilray Inc (TLRY) Financial Statements

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.49

+0.05 (+11.81%)

USD 0.49B

0.04B

USD 1.68(+240.97%)

USD 10.19 (+1969.88%)

Icon

TLRY

Tilray Inc (USD)
COMMON STOCK | NSD
USD 0.49
+0.05 ( +11.81%)

Tilray Inc (TLRY) Annual Income Statement (USD)

TLRY Quarterly Financials (USD)

Frequently Asked Questions About Tilray Inc (TLRY) Stock

Tilray Inc's (TLRY) last reported annual revenue was USD 788.94 Million.

Tilray Inc's (TLRY) annual revenue growth rate based on the revenue reported in the past 5 years is : 35.11%

Tilray Inc's(TLRY) is not profitable as of its last reported annual financials.

The net profit margin for Tilray Inc's(TLRY) from its laster reported year is -31.05%

The return on equity (ROE) for Tilray Inc's(TLRY) from its last reported annual financials is : -30.73%

The return on assets (ROA) for Tilray Inc's(TLRY) from its last reported annual financials is : -1.63%

The return on invested capital (ROIC) for Tilray Inc's(TLRY) from its last reported annual financials is : -3.87%

The Debt to Equity ratio for Tilray Inc's(TLRY) from its last reported annual financials is : 8.36%

The dividend yield for Tilray Inc's(TLRY) from its laster reported year is 0.00%

Tilray Inc's(TLRY) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...